Home
ZBH

ZBH

Zimmer Biomet Holdings Inc.

as 05-20-2024 1:33pm EST

Health Care

Industrial Specialties

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

#11 in Best Under $200 Stocks

Founded:	1927	Country:	United States
Employees:	N/A	City:	WARSAW
Market Cap:	24.6B	IPO Year:	N/A
Target Price:	$138.53	AVG Volume (30 days):	1.3M
Analyst Decision:	Buy	Number of Analysts:	16
Dividend Yield:	0.80%	Dividend Payout Frequency:	Quarterly
EPS:	4.61	EPS Growth:	115.42
52 Week Low/High:	$102.00 - $147.50	Next Earning Date:	05-02-2024
Revenue:	$7,452,500,000	Revenue Growth:	4.85%
Revenue Growth (this year):	5.92%	Revenue Growth (next year):	4.71%

Share on Social Networks:

Stock Insider Trading Activity of Zimmer Biomet Holdings Inc. (ZBH)

Name	Ticker	Relationship	Date	Transaction	Cost Per Share	Shares	Total Value	Securities Owned After Transaction(s)	SEC Form 4
Yi Sang	ZBH	Group President, Asia Pacific	Mar 6 '24	Sell	$126.86	1,705	$216,296.30	18,179	SEC Form 4
Phipps Chad F	ZBH	Sr. VP/Gen Counsel/Secretary	Feb 22 '24	Sell	$128.61	25,546	$3,285,386.76	44,755	SEC Form 4
Phipps Chad F	ZBH	Sr. VP/Gen Counsel/Secretary	Feb 22 '24	Sell	$129.08	610	$78,739.23	44,145	SEC Form 4
Jafry Syed A.	ZBH	Director	Nov 9 '23	Buy	$104.75	2,135	$223,641.25	4,060	SEC Form 4